Teva Pharmaceutical Industries Newsroom

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Moomoo NewsAug 22 11:31 ET

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsAug 5 04:32 ET

Argus Research Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Moomoo NewsAug 2 11:31 ET

Evercore Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating

Moomoo NewsAug 2 08:31 ET

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $22

Moomoo NewsAug 2 04:33 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaAug 1 12:52 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsAug 1 06:37 ET

Barclays Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)

TipRanksJul 30 03:58 ET

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsJul 24 07:33 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJul 10 22:12 ET

Argus Upgrades Teva to Buy, Cites Recent Drug Approvals

Seeking AlphaJul 10 13:19 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJun 27 11:38 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJun 5 11:20 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 30 11:47 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 13 08:47 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 9 11:42 ET

Teva Upgraded at J.P. Morgan on Upcoming Catalysts

Seeking AlphaMar 8 10:24 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMar 8 08:12 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaFeb 12 05:27 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaFeb 5 08:45 ET